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Sfrp1 遺伝子は急性腎不全において腎線維化の進行を制御している 
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ABSTRACT 
Renal fibrosis is responsible for progressive renal diseases that cause chronic renal failure. Secreted 
Frizzled-related protein 1 (Sfrp1) is highly expressed in kidney, although little is known about connection between 
the protein and renal diseases. Here we focused on Sfrp1 to investigate its roles in renal fibrosis using a mouse 
model of unilateral ureteral obstruction (UUO). In wild-type mice, the expression of Sfrp1 protein was markedly 
increased after UUO. The kidneys from Sfrp1 knockout mice showed significant increase in expression of 
myofibrobast markers, alpha-smooth muscle actin (SMA). Sfrp1 deficiency also increased protein levels of the 
fibroblast genes, Vimentin, and decreased those of the epithelial genes, E-cadherin, indicated that enhanced 
epithelial-to-mesenchymal transition (EMT). There was no difference in the levels of canonical Wnt signaling; 
rather the levels of phosphorylated c-Jun and JNK were more increased in the Sfrp1-/- obstructed kidney. Moreover, 
the apoptotic cell population was significantly elevated in the obstructed kidneys from Sfrp1-/- mice following 
UUO, but was slightly increased in those from wild-type mice. These results indicate that Sfrp1 is required for 





















子は直接 Wnt に結合し，Wnt シグナルを阻害する
分泌性因子と考えられている(4)．Sfrp 分子種の


















































































































３．Sfrp1 は EMT を介した腎線維化に関与する 
 腎不全時においてSfrp1の欠損が線維化を悪化
させることから，腎不全時における Sfrp1 ノック 
アウトマウスの線維化の状況を，上皮間葉転換
（EMT）の遺伝子マーカーを用いて検討した．そ 

































図 1 腎不全時 Sfrp1 遺伝子が増加する 
（A）片側尿管結紮（UUO）を用いた腎不全の模式図（B）腎不全時における Sfrp1 タンパクの挙動 
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